Related Experiment Video
Updated: Mar 24, 2026
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Elevated CA19-9 in IgG4-Related Autoimmune Pancreatitis: A Single-Center Retrospective Cohort Study
Dong-Ge Han1,2,3, Su-Yu Li4, Rui-Ting Zhou1,2,3
1The First College of Clinical Medical Science, China Three Gorges University, Yichang, People's Republic of China.
Background:
IgG4-related autoimmune pancreatitis (IgG4-AIP) is a rare autoimmune pancreatic disorder, with elevated carbohydrate antigen 19-9 (CA19-9) observed in some patients.
Objective:
This study aims to compare the clinical features of IgG4-AIP patients with elevated versus normal CA19-9 levels to clarify the clinical significance of CA19-9 in this condition.
Methods:
This study conducted a retrospective analysis of the clinical data of 41 patients with IgG4-AIP who underwent CA19-9 testing at Yichang Central People's Hospital from January 2019 to April 2025. In this study, the normal reference range for CA19-9 levels was defined as 0 to 39 U/mL.
Results:
Among the 41 patients with IgG4-AIP, 23 patients (56.10%) had normal CA19-9 levels, while 18 patients (43.90%) exhibited elevated CA19-9 levels. Patients with elevated CA19-9 levels were more likely to be misdiagnosed as having pancreatic tumors (55.56% vs. 13.04%) and had a higher incidence of bile duct involvement (88.89% vs. 26.09%), whereas the incidence of lymph node involvement (22.22% vs. 56.52%) was lower (P<0.05). Compared to the normal CA19-9 group, patients in the elevated CA19-9 group had significantly higher levels of total bilirubin (TBIL), direct bilirubin (DBIL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), and complement C3 (C3) (P<0.05). Additionally, CA19-9 levels demonstrated a moderate positive correlation with TBIL, DBIL, ALT, AST, GGT, and ALP (P<0.05). However, no significant correlation was found between CA19-9 levels and C3 or serum immunoglobulin G4 (IgG4) levels (P>0.05).
Conclusion:
Patients with elevated CA19-9 levels in IgG4-AIP exhibit more complex clinical features. Clinicians should consider CA19-9 level differences when evaluating and managing IgG4-AIP patients to guide personalized diagnostic and therapeutic strategies.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...